2021 Feb 4 - ACD | Rutgers Cancer Institute of New Jersey
David Remedios
Sales Development Representative, Advanced Cell Diagnostics
Watch Video:
Emily Martersteck, M.S.,
Field Application Scientist (FAS), Advanced Cell Diagnostics
Josh Vieth, Ph.D.
Managing Director, Immune Monitoring & Advanced Genomics, Rutgers Cancer Institute of New Jersey
Outline:
Using RNAscope ISH to detect cancer and immune markers in the tumor microenvironment at single-cell resolution
The study of the tumor microenvironment (TME) expands the understanding of cancer initiation, progression, and metastases. The RNAscope assay is an ideal solution to analyze specific cell types and states infiltrated in the TME within the morphological context.
With RNAscope you can identify and characterize immune cell types, cytokines, chemokines, transcription factors, checkpoint markers, and more, all at the single cell level.
